AUSTIN, Texas, June 03, 2026 (GLOBE NEWSWIRE) -- BioMedWire Editorial Coverage: With oncology drug-development expenses continuing to rise and regulatory approvals becoming harder to secure, ...
The next article I wanted to discuss for the Biotech Analysis Central Model 10+ Portfolio Pick #18 is a biotech by the name of Annovis Bio (ANVS)The reason why I wanted to go over this biotech next as ...
Cell-cell interaction data captures how cells influence one another and how those interactions shape biological function. While single-cell sequencing and spatial biology have tra ...
The next article I wanted to discuss for the Biotech Analysis Central Model 10+ Portfolio Pick #5 is about a biotech by the name of Cytokinetics (CYTK). The reason why I believe that it is important ...
INDIANAPOLIS, Sept. 9, 2025 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced the launch of Lilly TuneLab, an artificial intelligence and machine learning (AI/ML) platform that ...
After 15 years at Genentech, where his work has spanned small molecules, antibody drug conjugates, and now cell and gene therapies – Don has become one of the company’s most vocal champions for the ...
Detailed price information for Sarepta Therapeutics (SRPT-Q) from The Globe and Mail including charting and trades.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results